dc.relation.reference | Reference
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., and Lynch, D. H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181, 71-77.
Bai, C., Connolly, B., Metzker, M. L., Hilliard, C. A., Liu, X., Sandig, V., Soderman, A., Galloway, S. M., Liu, Q., Austin, C. P., and Caskey, C. T. (2000). Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A 97, 1230-1235.
Blair, P. J., Riley, J. L., Harlan, D. M., Abe, R., Tadaki, D. K., Hoffmann, S. C., White, L., Francomano, T., Perfetto, S. J., Kirk, A. D., and June, C. H. (2000). CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med 191, 651-660.
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., and Banchereau, J. (2001). Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540-1543.
Brunner, F., Stessel, H., Watzinger, N., Loffler, B. M., and Opie, L. H. (1995). Binding of endothelin to plasma proteins and tissue receptors: effects on endothelin determination, vasoactivity, and tissue kinetics. FEBS Lett 373, 97-101.
Chen, N. J., Huang, M. W., and Hsieh, S. L. (2001). Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol 166, 270-276.
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. D. (1994). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762.
Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., and Krammer, P. H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
Hsu, T. L., Chang, Y. C., Chen, S. J., Liu, Y. J., Chiu, A. W., Chio, C. C., Chen, L., and Hsieh, S. L. (2002). Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol 168, 4846-4853.
Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
Kammer, G. M., Perl, A., Richardson, B. C., and Tsokos, G. C. (2002). Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 46, 1139-1154.
Kennedy, N. J., Kataoka, T., Tschopp, J., and Budd, R. C. (1999). Caspase activation is required for T cell proliferation. J Exp Med 190, 1891-1896.
Kim, S., McAuliffe, W. J., Zaritskaya, L. S., Moore, P. A., Zhang, L., and Nardelli, B. (2004). Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect Immun 72, 89-93.
Langstein, J., Michel, J., and Schwarz, H. (1999). CD137 induces proliferation and endomitosis in monocytes. Blood 94, 3161-3168.
Liu, Y. L., Zhu, G. S., Chen, J. S., Na, L. Y., Hua, J., Pang, W. Q., and Xu, R. R. (2000). Synthesis and structural characterization of a new open-framework tin(II) phosphate: [Sn4(PO4)3]-.0.5[C4N2H12]2+. Inorg Chem 39, 1820-1822.
Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X., et al. (2002). TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492.
Mixter, P. F., Russell, J. Q., and Budd, R. C. (1994). Delayed kinetics of T lymphocyte anergy and deletion in lpr mice. J Autoimmun 7, 697-710.
Nagata, S., and Suda, T. (1995). Fas and Fas ligand: lpr and gld mutations. Immunol Today 16, 39-43.
Ohshima, K., Haraoka, S., Sugihara, M., Suzumiya, J., Kawasaki, C., Kanda, M., and Kikuchi, M. (2000). Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett 160, 89-97.
Otsuki, T., Tomokuni, A., Sakaguchi, H., Aikoh, T., Matsuki, T., Isozaki, Y., Hyodoh, F., Ueki, H., Kusaka, M., Kita, S., and Ueki, A. (2000). Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol 119, 323-327.
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998). Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699-703.
Roth, W., Isenmann, S., Nakamura, M., Platten, M., Wick, W., Kleihues, P., Bahr, M., Ohgaki, H., Ashkenazi, A., and Weller, M. (2001). Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res 61, 2759-2765.
Russell, J. H., and Wang, R. (1993). Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol 23, 2379-2382.
Schmitz, I., Krueger, A., Baumann, S., Schulze-Bergkamen, H., Krammer, P. H., and Kirchhoff, S. (2003). An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J Immunol 171, 2930-2936.
Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H., and Ware, C. F. (2001). Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167, 6330-6337.
Shi, G., Luo, H., Wan, X., Salcedo, T. W., Zhang, J., and Wu, J. (2002). Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100, 3279-3286.
Stuber, E., Neurath, M., Calderhead, D., Fell, H. P., and Strober, W. (1995). Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2, 507-521.
Suzuki, I., and Fink, P. J. (1998). Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 187, 123-128.
Suzuki, I., and Fink, P. J. (2000). The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc Natl Acad Sci U S A 97, 1707-1712.
Tsai, H. F., Lai, J. J., Chou, A. H., Wang, T. F., Wu, C. S., and Hsu, P. N. (2004). Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum 50, 629-639.
Tsokos, G. C., and Liossis, S. N. (1999). Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 20, 119-124.
Tucek-Szabo, C. L., Andjelic, S., Lacy, E., Elkon, K. B., and Nikolic-Zugic, J. (1996). Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. J Immunol 156, 192-200.
van Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
Wan, X., Zhang, J., Luo, H., Shi, G., Kapnik, E., Kim, S., Kanakaraj, P., and Wu, J. (2002). A TNF family member LIGHT transduces costimulatory signals into human T cells. J Immunol 169, 6813-6821.
Wiley, S. R., Goodwin, R. G., and Smith, C. A. (1996). Reverse signaling via CD30 ligand. J Immunol 157, 3635-3639.
Wu, S. F., Liu, T. M., Lin, Y. C., Sytwu, H. K., Juan, H. F., Chen, S. T., Shen, K. L., Hsi, S. C., and Hsieh, S. L. (2004). Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication. J Leukoc Biol 75, 293-306.
Yang, Y., Mercep, M., Ware, C. F., and Ashwell, J. D. (1995). Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med 181, 1673-1682.
Yu, K. Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., and Kwon, B. S. (1999). A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 274, 13733-13736.
Zhang, J., Salcedo, T. W., Wan, X., Ullrich, S., Hu, B., Gregorio, T., Feng, P., Qi, S., Chen, H., Cho, Y. H., et al. (2001). Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 107, 1459-1468.
Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H., and Lenardo, M. J. (1995). Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351. | en |